StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Janney Capital Starts Sarepta Therapeutic (SRPT) at Neutral
April 20, 2016 8:03 AM
Janney Capital initiated coverage on Sarepta Therapeutic (NASDAQ: SRPT) with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
New Coverage
Next Articles
CRL 'Most Logical Outcome' for Sarepta's (SRPT) Eteplirsen - Janney Montgomery Scott
April 21, 2016 9:29 AM
Sarepta Therapeutics (SRPT) Sees Quick Sell-Off Following FDA Briefing Docs
April 21, 2016 8:08 AM